Trial · NCT00042289
Participant flow235
How many started, completed or left each group, period by period.
1 to 20 of 235
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | DRV/RTV 600 or 800 or 900/100mg b.i.d. Then 800 or 900/100mg b.i.d. Then 600/100mg b.i.d. | 26 | |
| Overall Study | STARTED | DTG 50mg q.d. | 30 | |
| Overall Study | STARTED | TAF 25mg q.d. | 27 | |
| Overall Study | STARTED | TAF 10mg q.d. w/COBI | 33 | |
| Overall Study | STARTED | TAF 25mg q.d. w/COBI or RTV Boosting | 29 | |
| Overall Study | STARTED | EVG/COBI 150/150mg q.d. | 31 | |
| Overall Study | STARTED | DRV/COBI 800/150 mg q.d. | 28 | |
| Overall Study | STARTED | ATV/COBI 300/150 mg q.d. | 12 | |
| Overall Study | STARTED | EFV 600 mg q.d. (Outside THA) | 27 | |
| Overall Study | STARTED | EFV 600mg q.d. and at Least One 1st Line TB Drug | 24 | |
| Overall Study | STARTED | LPV/RTV 800/200mg b.i.d. and at Least One 1st Line TB Drug | 2 | |
| Overall Study | STARTED | No ARVs and at Least Two 1st Line TB Drugs | 27 | |
| Overall Study | STARTED | At Least Two 2nd Line TB Drugs w/ or w/Out ARVs | 13 | |
| Overall Study | STARTED | DRV/COBI 800/150mg q.d. or ATV/COBI 300/150mg q.d With 30-35ug EE | 2 | |
| Overall Study | STARTED | DRV/COBI 800/150mg q.d. or ATV/COBI 300/150mg q.d With ENG | 6 | |
| Overall Study | STARTED | EFV 600mg q.d. With 30-35ug EE | 29 | |
| Overall Study | STARTED | ATV/RTV/TFV 300/100/300mg q.d. With 30-35ug EE | 28 | |
| Overall Study | STARTED | NVP 200mg b.i.d | 12 | |
| Overall Study | STARTED | ABC 300mg b.i.d | 26 | |
| Overall Study | STARTED | LPV/RTV Arm 1: 400/100mg b.i.d | 17 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00042289/flow